Eosinophilic Granulomatosis with Polyangiitis Relapse after COVID-19 Vaccination: A Case Report

Background: We here describe the case of a 71-year-old Caucasian woman previously diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA) that had been treated with Mepolizumab, an anti-IL5 monoclonal antibody, since 2019 with a good clinical response. Methods: She had a mild COVID-19 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Costanzo, Giulia, Ledda, Andrea Giovanni, Ghisu, Alessandra, Vacca, Matteo, Firinu, Davide, Del Giacco, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779858/
https://www.ncbi.nlm.nih.gov/pubmed/35062675
http://dx.doi.org/10.3390/vaccines10010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779858/
https://www.ncbi.nlm.nih.gov/pubmed/35062675
http://dx.doi.org/10.3390/vaccines10010013

Ejemplares similares